ARCHIVES

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

This article is from The Cancer Letter archive.

Vol. 28 No. 04 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

DCE Board Approves Epidemiology Contract Recompetitions

March 17, 1995

Voluntary Organizations: Myles Cunningham elected ACS President

November 8, 1996

International Group Plans Survey On Thrombosis Risk

July 27, 2001

Six Surgical Oncology Grants To Be Funded

June 8, 1984

NCI Seeks Changes In CIS Funding Plan With Next Recompetition

April 24, 1987

Funding Opportunities

November 15, 2002